Sun Pharma Laboratories has informed that with reference to the earlier announcement regarding Outcome of the Adjourned Board Meeting held on May 26, 2017 where the Company have mentioned that Uday Baldota ‘would be shifting to United States of America, to look after the business of Taro Pharmaceutical Industries, a subsidiary of the Company’ request to read it as ‘would be shifting to United States of America, to look after the business of Taro Pharmaceutical Industries Limited, a subsidiary of the Parent Company, Sun Pharmaceutical Industries Limited’.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| EMAMILTD7 | 423.00 |
| ICICINXT50 | 74.01 |
| Arihant Mangal Scheme | |
| PropShare Celestia | |
| TGV Securities | |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: